| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Hideyuki Takeshima
|
|||||||
| GSE222736 |
DNA methylation profiles of mouse leukocyte
|
7 | Hideyuki Takeshima | Nov 09, 2023 | ||||
| GSE211704 |
Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer
|
50 | Hideyuki Takeshima | Sep 06, 2022 | ||||
| GSE211580 |
Frequent involvement of chromatin remodeler alterations in gastric field cancerization
|
9 | Hideyuki Takeshima | Aug 31, 2022 | ||||
| GSE171429 |
scRNA-seq of DAC-treated and mock-treated HCT116.
|
2 | Hideyuki Takeshima | Apr 10, 2021 | ||||
| GSE171622 |
Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level
|
13 | Hideyuki Takeshima | Apr 07, 2021 | ||||
| GSE149255 |
DNA methylation analysis of cloned HCT116 cells treated with a DNA demethylating drug.
|
11 | Hideyuki Takeshima | Oct 02, 2020 | ||||
| GSE117528 |
DNA methylation statuses of 293FT cells with TET depletion and NOC18 treatment
|
32 | Hideyuki Takeshima | Sep 30, 2020 | ||||
| GSE74007 |
H3K27me3 analysis in mouse colonic epithelial cells
|
3 | Hideyuki Takeshima | Oct 15, 2015 | ||||
| GSE54758 |
DNA methylation, H3K27me3, and gene expression statuses of human cancer cell lines and normal cells.
|
24 | Hideyuki Takeshima | Dec 31, 2014 | ||||
| GSE28284 |
Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction.
|
26 | Hideyuki Takeshima | Jun 06, 2011 | ||||
| GSE15154 |
The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands
|
21 | Hideyuki Takeshima | Jul 31, 2009 |
